{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:32:10Z","timestamp":1791055930820,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.autrev.2010.09.004","type":"journal-article","created":{"date-parts":[[2010,9,20]],"date-time":"2010-09-20T08:14:47Z","timestamp":1284970487000},"page":"144-149","source":"Crossref","is-referenced-by-count":107,"title":["Subcutaneous immunoglobulin in polymyositis and dermatomyositis: A novel application"],"prefix":"10.1016","volume":"10","author":[{"given":"Maria Giovanna","family":"Danieli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Pettinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Logullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2010.09.004_bb0005","doi-asserted-by":"crossref","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis. New Engl J Med 1975; 292: 344\u20137 & 403\u20137.","DOI":"10.1056\/NEJM197502202920807"},{"issue":"3","key":"10.1016\/j.autrev.2010.09.004_bb0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","article-title":"Immunotherapy of myositis: issues, concerns and future prospects","volume":"6","author":"Dalakas","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2010.09.004_bb0015","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"New Engl J Med"},{"key":"10.1016\/j.autrev.2010.09.004_bb0020","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.tmrv.2007.01.002","article-title":"Guidelines to the use of intravenous immunoglobulin for neurologic conditions","volume":"21","author":"Feasby","year":"2007","journal-title":"Transfus Med Rev"},{"issue":"2","key":"10.1016\/j.autrev.2010.09.004_bb0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2009.04.003","article-title":"Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis","volume":"9","author":"Danieli","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2010.09.004_bb0030","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.autrev.2010.03.003","article-title":"Information for healthcare providers on general features of IGIV with emphasis on differences between commercially available products","volume":"9","author":"Gurcan","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2010.09.004_bb0035","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.iac.2008.07.002","article-title":"Subcutaneous administration of IgG","volume":"4","author":"Berger","year":"2008","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.autrev.2010.09.004_bb0040","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.autrev.2010.09.004_bb0045","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00004691-199304000-00002","article-title":"The electrodiagnostic examination with myopathies","volume":"10","author":"Wilbourn","year":"1993","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.autrev.2010.09.004_bb0050","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0895-4356(98)00094-8","article-title":"The Italian sf-36 health survey: translation, validation and norming","volume":"5","author":"Apolone","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"Suppl1","key":"10.1016\/j.autrev.2010.09.004_bb0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2249.2009.04028.x","article-title":"Intravenous immunoglobulin in immunodeficiencies and autoimmunity","volume":"158","author":"Fernandez-Cruz","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2010.09.004_bb0060","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s10067-008-0892-2","article-title":"Subcutaneous immunoglobulin administration: an alternative to intravenous infusion as adjuvant treatment for dermatomyositis?","volume":"27","author":"Schleinitz","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2010.09.004_bb0065","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/08916930902785363","article-title":"Intravenous immunoglobulin therapy for autoimmune diseases","volume":"42","author":"Arnson","year":"2009","journal-title":"Autoimmunity"},{"issue":"2\u20133","key":"10.1016\/j.autrev.2010.09.004_bb0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12016-009-8155-9","article-title":"Evidence for the use of intravenous immunoglobulins\u2014a review of the literature","volume":"38","author":"Kivity","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2010.09.004_bb0075","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.autrev.2008.04.011","article-title":"Role of natural antibodies in immune homeostasis: IVIg perspective","volume":"7","author":"Vani","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2010.09.004_bb0080","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2008.04.012","article-title":"What is the contents of the magic draft IVIg?","volume":"7","author":"Seite","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2010.09.004_bb0085","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.autrev.2008.03.015","article-title":"Natural anti-Siglec autoantibodies mediate potential immunoregulatory mechanisms: implications for the clinical use of intravenous immunoglobulins (IVIg)","volume":"7","author":"von Gunten","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2010.09.004_bb0090","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1136\/ard.2003.015453","article-title":"Long-term effectivenss of intravenous immunoglobulin in Churg\u2013Strauss syndrome","volume":"63","author":"Danieli","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2010.09.004_bb0095","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2008.04.001","article-title":"Intravenous immunoglobulin\u2014indications and mechanisms in cardiovascular diseases","volume":"7","author":"Nussinovitch","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2010.09.004_bb0100","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.4049\/jimmunol.179.8.5571","article-title":"Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function","volume":"179","author":"Kessel","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2010.09.004_bb0105","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2353\/ajpath.2009.080422","article-title":"Role of regulatory T cells in a new mouse model of experimental autoimmune myositis","volume":"174","author":"Allenbach","year":"2009","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.autrev.2010.09.004_bb0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10875-007-9169-9","article-title":"Prospective study on CVID patients with adverse reactions to intravenous or subcutaneous IgG administration","volume":"28","author":"Quinti","year":"2008","journal-title":"J Clin Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997210002004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997210002004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T22:43:37Z","timestamp":1559688217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997210002004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1568997210002004"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2010.09.004","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}